Octant is engineering a new generation of drug discovery.

Octant is developing a multiplexed technology that uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells, paving the way for a new modality for drug discovery.
-
Industry
-
Milestones
- Lux investment: 2017
-
Founders
- Sri Kosuri
- Ramsey Homsany
LUX Partners
-
Latest Tweets
- Check out this blogpost by @MollyGasp and @winnieLLiu! They share how @OctantBio multiplexed tech accelerates the… https://t.co/DbH1AIMIy8
- 2021 - let's go. Octant is #HIRINGNOW for multiple positions. Join our team! https://t.co/tzAjz0vbrC. .… https://t.co/agWqTUeijR
- Happy new year! If you’re interested in the Fall 2021 SBA program, please submit your application by Friday. See… https://t.co/6TN4Wo0khh